Document Detail


Cutaneous mucormycosis: report of five cases and review of the literature.
MedLine Citation:
PMID:  18684680     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Mucormycosis is a highly aggressive fungal infection caused by Zygomycetes, from the order of Mucorales. This infection commonly presents an aggressive and rapid course and typically affects immunocompromised patients. Mucormycosis can manifest in different clinical patterns and locations. Although the correct diagnosis is often difficult, an early identification is essential for patient survival. Several clinical forms of mucormycosis are recognised. Cutaneous mucormycosis is less common than other clinical forms, but potentially lethal if treatment is not rapid. Tissue examination by histopathology and culture confirms the fungal infection. Standard treatment includes antifungal therapies associated with surgical debridement. We report five different cases of cutaneous mucormycosis treated in our institution and the management carried out in each case.
Authors:
M E Arn?iz-Garc?a; D Alonso-Pe?a; M del Carmen Gonz?lez-Vela; J D Garc?a-Palomo; J R Sanz-Gim?nez-Rico; A M Arn?iz-Garc?a
Publication Detail:
Type:  Journal Article; Review     Date:  2008-08-05
Journal Detail:
Title:  Journal of plastic, reconstructive & aesthetic surgery : JPRAS     Volume:  62     ISSN:  1878-0539     ISO Abbreviation:  J Plast Reconstr Aesthet Surg     Publication Date:  2009 Nov 
Date Detail:
Created Date:  2010-01-19     Completed Date:  2010-02-18     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101264239     Medline TA:  J Plast Reconstr Aesthet Surg     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  e434-41     Citation Subset:  IM    
Copyright Information:
(c) 2009 British Association of Plastic, Reconstructive and Aesthetic Surgeons. Published by Elsevier Ltd. All rights reserved.
Affiliation:
Department of Plastic and Reconstructive Surgery, Infectious Diseases Unit, Marqu?s de Valdecilla University Hospital, Santander, Spain. elearnaiz@hotmail.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Antifungal Agents / therapeutic use
Combined Modality Therapy
Debridement / methods
Dermatomycoses / diagnosis*,  immunology,  therapy*
Follow-Up Studies
Humans
Hyperbaric Oxygenation / methods
Immunocompromised Host*
Immunohistochemistry
Male
Mucormycosis / diagnosis*,  immunology,  therapy*
Risk Assessment
Sampling Studies
Severity of Illness Index
Skin Transplantation / methods
Treatment Outcome
Wound Healing / physiology
Young Adult
Chemical
Reg. No./Substance:
0/Antifungal Agents

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  T-anastomosis in microsurgical free flap reconstruction: an overview of clinical applications.
Next Document:  Additional familial case of subtotal leukonychia and sebaceous cysts (Bauer syndrome): belong the ne...